Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: A pragmatic, double-blind, randomized controlled trial

Alimentary Pharmacology and Therapeutics

Volumn 17, Issue 4, 2003, Pages 517-523

  Caprilli, R ^a   Cottone, M ^b   Tonelli, F ^c   Sturniolo, G ^d   Castiglione, F ^e   Annese, V ^f   Papi, C ^g   Viscido, A ^a   Camma C ^h   Corrao, G ⁱ   Latella, G ^j  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^g SAN FILIPPO NERI HOSPITAL   (Italy)

^h CNR   (Italy)

ⁱ UNIVERSITY OF MILANO BICOCCA   (Italy)

^j UNIVERSITY OF L'AQUILA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE;

ADULT; ARTICLE; CLINICAL TRIAL; COLON RESECTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPEPSIA; FEMALE; HUMAN; ILEUM RESECTION; LEG CRAMP; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROHN DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MESALAMINE; PATIENT COMPLIANCE; POSTOPERATIVE COMPLICATIONS; RECURRENCE; TREATMENT OUTCOME;

EID: 0344687372     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01462.x     Document Type: Article

References (21)

1. Caprilli R, Andreoli A, Capurso L, et al. Oral mesalazine (5-aminosalicylic acid: Asacol) for the prevention of postoperative recurrence of CD. Aliment Pharmacol Ther 1994; 8: 35-43.
2. Brignola C, Cottone M, Pera A, et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Gastroenterology 1995; 108: 345-9.
3. McLeod RS, Wolff BG, Steinhart H, et al. Prophylactic mesalazine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995; 109: 404-13.
4. Florent C, Cortot A, Quandale P, et al. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Eur J Gastroenterol Hepatol 1996; 8: 229-33.
5. Sutherland LR, Martin F, Bailey RJ, et al. A randomized, placebo-controlled, double-blind trial of mesalazine in the maintenance of remission of Crohn's disease. Gastroenterology 1997; 112: 1069-77.
6. Lochs H, Mayer M, Fleig WE, et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalazine. European Cooperative Crohn's Disease Study VI. Gastroenterology 2000; 118: 264-73.
7. Cammà C, Giunta M, Rosselli M, Cottone M. 5-aminosalicylic acid in the maintenance treatment of Crohn's disease: a metaanalysis adjusted for confounding variables. Gastroenterology 1997; 113: 1465-73.
8. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995; 108: 1617-21.
9. Rutgeerts P, Assche GV, D'Haens G, et al. Ornidazol for prophylaxis of post-operative Crohn's disease: final results of a double blind placebo controlled trial. Gastroenterology 2002; 122: A80(Abstract).
10. Korelitz B, Hanauer S, Rutgeerts P, Present D, Peppercorn M. Post-operative prophylaxis with 6-MP. 5-ASA or placebo in Crohn's disease: a 2 year multicenter trial. Gastroenterology 1998; 114: A1011(Abstract).
11. Hellers G, Cortot A, Jewell D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology 1999; 116: 294-300.
12. Ewe K, Bottger T, Burh HJ, Ecker KW, Otto HF. Lowdose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomised placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol 1999; 11: 277-82.
13. Papi C, Lucchetti R, Gili L, Montanti S, Koch M, Capurso L. Budesonide in the treatment of Crohn's disease: a meta-analysis. Aliment Pharmacol Ther 2000; 14: 1419-28.
14. Colombel JF, Rutgeerts P, Malchow H, et al. Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease. Gut 2001; 49: 42-6.
15. Cottone M, Cammà C, Mesalamine and relapse prevention in Crohn's disease. Gastroenterology 2000; 118: 597.
16. Cottone M, Cammà C. Reply to: Mesalamine maintenance therapy for Crohn's disease. Gastroenterology 2001; 120: 585-6.
17. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990; 99: 956-63.
18. Sandborn WJ, Feagan BJ, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002; 122: 512-30.
19. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-44.
20. Cammà C, Viscido A, Latella G, Caprilli R, Cottone M. Mesalamine in the prevention of clinical and endoscopic postoperative recurrence of Crohn's disease: a meta-analysis. Digest Liver Dis 2002; 34: A86(Abstract).
21. D'Haens G, Rutgeerts P. Postoperative recurrence of Crohn's disease: pathophysiology and prevention, Inflam Bowel Dis 1999; 5: 295-303.